Drug Trial Radar · NCT06605105
Phase III Long-term Extension Trial to Assess Safety and Efficacy of CYB003 in MDD (EXTEND)
Last checked: Nov 19, 2026Latest source record: Sep 25, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Enrolling by invitation
Enrollment
468
Planned (sponsor's estimate)
Start
Jul 18, 2025
Primary completion
Jun 6, 2028
Study completion Jun 6, 2028
Sponsor
- Lead sponsor
- Cybin IRL LimitedIndustry
- Sponsor type
- Industry
- Collaborators
- Worldwide Clinical Trials
- First posted
- Sep 20, 2024
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 85 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a long- term extension of the double-blind trials APPROACH (CYB003-002) and EMBRACE (CYB003-003). Its aim is to examine the safety and long-term efficacy of CYB003 in participants with MDD.
Conditions
- Major Depressive Disorder
Interventions
CYB003Drug
CYB003 is a deuterated psilocin analog
Primary outcomes
What the sponsor says the trial is designed to measure.
- Montgomery-Asberg Depression Rating Scale (MADRS)Time frame: Baseline, Day 28, Day 56, Day 84, Day 112, Day 140, Day 168, Day 196, Day 244, Day 252, Day 280, Day 301; additional assessments at Day -15, Day -1, Day 2, Day 10, Day 17, Day 21, Day 23, Day 31, Day 42 if non-response or relapse criteria met
Locations
49 sites in 5 countries. Site status is shown where the registry gives one.
Scottsdale Research Institute
Phoenix, Arizona
Behavioral Research Specialists, LLC
Glendale, California
Kadima Neuropsychiatry Institute
La Jolla, California
TRIP Clinic and Psychedelic Science Institute
Los Angeles, California
CalNeuro Research Group
Los Angeles, California
Lipov Medical Group
Los Angeles, California
Excell Research, Inc
Oceanside, California
Open Mind Collective / UCSF Medical Center - Mount Zion
San Francisco, California
Inland Psychiatric Medical Group Inc (IPMG Research)
San Juan Capistrano, California
Mountain View Clinical Research
Denver, Colorado
Starlight Clinical Research
Evergreen, Colorado
Research Centers of America
Hollywood, Florida
Clinical Neuroscience Solutions
Jacksonville, Florida
K2 Medical Research
Lady Lake, Florida
Segal Trials Center for Psychedelic Research
Lauderhill, Florida
Accel Research Sites - Maitland
Maitland, Florida
K2 Medical Research
Maitland, Florida
Clinical Neuroscience Solutions, Inc
Orlando, Florida
Charter Research
Orlando, Florida
Combined Research Orlando Phase I-IV
Orlando, Florida
Cenexel iResearcvh Atlanta, LLC
Atlanta, Georgia
Atlanta Center For Medical Research
Atlanta, Georgia
CenExel iResearch
Savannah, Georgia
Uptown Research Institute
Chicago, Illinois
Psychiatric Medicine Associates, LLC
Skokie, Illinois
Psychiatric Medicine Associates
Skokie, Illinois
Sunstone Medical, PC
Rockville, Maryland
Adams Clinical Boston
Boston, Massachusetts
Elixia Health
Springfield, Massachusetts
Adams Clinical
Watertown, Massachusetts
Institute for Integrative Therapies
Eden Prairie, Minnesota
Redbird Research
Las Vegas, Nevada
Global Medical Institutes, Princeton Medical Institute
Princeton, New Jersey
Bio Behavioral Health
Toms River, New Jersey
Adams Clinical Harlem
New York, New York
Adams Clinical Bronx
The Bronx, New York
Neurobehavioral Clinical Research
Canton, Ohio
Adams Clinical Philadelphia
Philadelphia, Pennsylvania
Clinical Neuroscience Solutions, CNS Healthcare
Memphis, Tennessee
Adams Clinical Dallas
DeSoto, Texas
Showing 40 of 49 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.